151 related articles for article (PubMed ID: 27166269)
21. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
22. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
23. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.
Li D; Zhang Y; Li Z; Wang X; Qu X; Liu Y
Tumour Biol; 2015 Dec; 36(12):9431-6. PubMed ID: 26124003
[TBL] [Abstract][Full Text] [Related]
24. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
25. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
26. NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.
Zhang Z; She J; Yang J; Bu X; Ji G; Zhu S; He S; Chu D
Mol Carcinog; 2018 Jun; 57(6):762-771. PubMed ID: 29500881
[TBL] [Abstract][Full Text] [Related]
27. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
28. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
29. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
Jang BG; Lee BL; Kim WH
Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
[TBL] [Abstract][Full Text] [Related]
30. Translation elongation factor eEF1Bα is identified as a novel prognostic marker of gastric cancer.
Jia L; Yang T; Gu X; Zhao W; Tang Q; Wang X; Zhu J; Feng Z
Int J Biol Macromol; 2019 Apr; 126():345-351. PubMed ID: 30572058
[TBL] [Abstract][Full Text] [Related]
31. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and Prognostic Significance of Epithelial Gremlin1 Expression in Gastric Cancer.
Honma R; Sakamoto N; Ishikawa A; Taniyama D; Fukada K; Hattori T; Sentani K; Oue N; Tanabe K; Ohdan H; Yasui W
Anticancer Res; 2018 Mar; 38(3):1419-1425. PubMed ID: 29491067
[TBL] [Abstract][Full Text] [Related]
33. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer.
Wang D; Li T; Ye G; Shen Z; Hu Y; Mou T; Yu J; Li S; Liu H; Li G
PLoS One; 2015; 10(4):e0122697. PubMed ID: 25860956
[TBL] [Abstract][Full Text] [Related]
35. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
36. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
37. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Zhang XG; Song BT; Liu FJ; Sun D; Wang KX; Qu H
Clin Transl Oncol; 2016 Jul; 18(7):700-7. PubMed ID: 26489425
[TBL] [Abstract][Full Text] [Related]
38. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
39. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
40. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
